AREDS2 at ten years: lutein and zeaxanthin instead of beta carotene
Long-term AREDS2 follow-up supported replacing beta carotene with lutein and zeaxanthin. The revised formula retained benefit for people at risk of late AMD without increasing lung-cancer risk.
doi: 10.1001/jamaophthalmol.2022.1640